Evidence map›Paper›PMID 39511921›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Dementia risk reduction in the African context: Multi-national implementation of multimodal strategies to promote healthy brain aging in Africa (the Africa-FINGERS project).

Chinedu T Udeh-Momoh, Rachel Maina, Udunna C Anazodo, Rufus Akinyemi, Lukoye Atwoli, Laura Baker, Darina Bassil, Karen Blackmon, Edna Bosire, Gloria Chemutai and 40 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Down syndrome in Africa: Challenges, opportunities, and future directions.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

50 authors.

Chinedu T Udeh-MomohBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Rachel MainaBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Udunna C AnazodoDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Rufus AkinyemiGlobal Brain Health Institute (GBHI), UCSF, San Francisco, California, USA.
Lukoye AtwoliBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Laura BakerSchool of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
Darina BassilHarvard Center for Population and Development Studies, Harvard University, Cambridge, Massachusetts, USA.
Karen BlackmonBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Edna BosireBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Gloria ChemutaiBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Lucia CrivelliDepartment of Cognitive Neurology, Fleni, Buenos Aires, Argentina.
Laz U EzeGlobal Brain Health Institute (GBHI), UCSF, San Francisco, California, USA.
Agustin IbanezGlobal Brain Health Institute (GBHI), UCSF, San Francisco, California, USA.
Dimitra KafetsouliAgeing Epidemiology Research Unit, School of Public Health, Imperial College London, London, UK.
Thomas K KarikariDepartment of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Linda KhakaliBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Manasi KumarGrossman School of Medicine, New York University, New York, New York, USA.
Imre LengyelSchool of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Celeste A de Jager LootsFINGERS Brain Health Institute, Stockholm, Sweden.
Francesca MangialascheDivision of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Sylvia MbuguaBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Zul MeraliBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Michelle MielkeSchool of Public Health Sciences, Wake Forest University School of Medicine, Winston Salem, North Carolina, USA.
Cyprian MostertBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Eunice MuthoniDepartment of Population Health, Aga Khan University, Nairobi, Kenya.
Olivera Nesic-TaylorBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Anthony NgugiDepartment of Population Health, Aga Khan University, Nairobi, Kenya.
Samuel NgukuDepartment of Radiology, Aga Khan University Hospital, Nairobi, Kenya.
Adesola OgunniyiInstitute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Adedoyin OgunyemiGlobal Brain Health Institute (GBHI), UCSF, San Francisco, California, USA.
Ozioma C OkonkwoDivision of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Njideka OkubadejoNeurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos, Nigeria.
Robert PerneczkySheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
Tunde PetoSchool of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Roselyter M Riang'aDepartment of Population Health, Aga Khan University, Nairobi, Kenya.
Mansoor SalehCancer Research Unit, Aga Khan University, Nairobi, Kenya.
Shaheen SayedDepartment of Pathology, Aga Khan University, Nairobi, Kenya.
Jasmit ShahBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Sheena ShahDepartment of Ophthalmology, Aga Khan University, Nairobi, Kenya.
Alina SolomonDivision of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Thomas ThesenBrain and Mind Institute, Aga Khan University, Nairobi, Kenya.
Dominic TrepelGlobal Brain Health Institute (GBHI), UCSF, San Francisco, California, USA.
Valentine UcheagwuDepartment of Psychology, Nnamdi Azikiwe University Awka, Anambra, Nigeria.
Victor ValcourGlobal Brain Health Institute (GBHI), UCSF, San Francisco, California, USA.
Sheila WaaDepartment of Radiology, Aga Khan University Hospital, Nairobi, Kenya.
Tamlyn WatermeyerCentre for Dementia Prevention, Clinical Brain Sciences, The University of Edinburgh, Edinburg, UK.
Jennifer YokoyamaUniversity of California, San Francisco, San Francisco, California, USA.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Miia KivipeltoDivision of Clinical Geriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Africa‐FINGERS Study Team

Funding

TDP-43 Loss-of-Function: Biology to BiomarkersP01AG019724 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Jennifer Merrilees · 2002 to 2026
$67.2M
Plasma brain-derived tau: a novel Alzheimer’s disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in bloodR01AG083874 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Thomas K Karikari · 2023 to 2026
$14.5M
Look AHEAD Sleep: Sleep-disordered breathing, circadian rest/activity rhythms, and the risk of Alzheimer's disease and related dementias in Look AHEADR01AG074562 · NIA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Adam Peter Spira, Chinedu Theresa Udeh-Momoh · 2021 to 2026
$8.8M
An automated machine learning approach to language changes in Alzheimer’s disease and frontotemporal dementia across Latino and English-speaking populationsR01AG075775 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARIA LUISA GORNO TEMPINI, Adolfo Martin Garcia · 2023 to 2026
$7.2M
US-South American Initiative for Genetic-Neural-Behavioral Interactions in Human Neurodegenerative ResearchR01AG057234 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Claudia Duran-Aniotz, Agustin M. Ibanez · 2019 to 2026
$6.1M
Circadian Disturbance and Dementia in Latin AmericaR01AG083799 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI Kun Hu, Agustin M. Ibanez · 2023 to 2026
$3.0M
Alzheimer's AssociationANID/FONDECYTDavos Alzheimer's Collaborative Global CohortsFogarty International Center [FIC]Global Brain Health InstituteMedical Research Council UKRI MRC/ MR/Y019822/1MULTI-PARTNER CONSORTIUM TO EXPAND DEMENTIA RESEARCH IN LATIN AMERICANational Institutes of AgingNIA NIH HHS P01 AG019724NIA NIH HHS R01 AG057234NIA NIH HHS R01 AG074562NIA NIH HHS R01 AG075775NIA NIH HHS R01 AG083799NIA NIH HHS R01 AG083874RoseTrees FoundationThe Alzheimer's AssociationUKRI MRCWellcome Leap and Temasek Trust Dynamic Resilience AwardWellcome Trust
6 · The paper itself

Abstract

Dementia prevention in Africa is critically underexplored, despite the continent's high prevalence of modifiable risk factors. With a predominantly young and middle-aged population, Africa presents a prime opportunity to implement evidence-based strategies that could significantly reduce future dementia cases and mitigate its economic impact. The multinational Africa-FINGERS program offers an innovative solution, pioneering culturally sensitive, multidomain interventions tailored to the unique challenges of the region.  Leveraging insights from landmark global studies such as Worldwide-FINGERS and Alzheimer's Disease Neuroimaging Initiative, the program employs a multideterminant precision prevention framework, grounded in community based systems dynamics. Africa-FINGERS further integrates cutting-edge state-of-the-art multimodal biomarker evaluations tailored to regional contexts, with the goal of advancing brain health and establishing a global standard for dementia prevention. This groundbreaking initiative highlights the potential for scalableand sustainable interventions, thus is poised to transform dementia risk reduction efforts across the continent. HIGHLIGHTS: Dementia rates are escalating in Africa, largely due to longer life spans and increased prevalence of modifiable risk factors. Yet, few regional interventions have directly targeted lifestyle factors to reduce dementia risk. The multinational Africa-FINGERS study will address this gap by adapting the successful FINGERS lifestyle intervention to African populations. Africa-FINGERS will pioneer a culturally informed, multidomain dementia risk reduction intervention in the African region through feasibility dementia prevention trials in rural and urban sites across Kenya and Nigeria in the first instance, enrolling 600 at-risk adults (≥ 50 years). The program adopts participatory research methods to develop culturally appropriate interventions and build infrastructure to evaluate dementia biomarkers from ante and post mortem samples. A cost-effectiveness analysis will be conducted to guide the strategic implementation of Africa-FINGERS into regional health systems. The Africa-FINGERS strategy aligns with the Worldwide-FINGERS framework and integrates the global Alzheimer's Disease Neuroimaging Initiative approach, emphasizing multimodal analysis.

Indexed as

DementiaRisk Reduction BehaviorAfricaBrainHealthy AgingHumansNeuroimagingRisk FactorsAlzheimer's diseasebrain bankingcommunity‐based participatory researchdementia prevention trialsfluid and neuroimaging biomarkershealth economicsimplementation scienceretinal imaging

Identifiers

PMID39511921
PMCPMC11667543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.